TANT_LABORATORIES_LIMITED - Accounts


Company Registration No. 4276285 (England and Wales)
TANT LABORATORIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
PAGES FOR FILING WITH REGISTRAR
TANT LABORATORIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
TANT LABORATORIES LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2019
31 December 2019
- 1 -
2019
2018
Notes
£
£
£
£
Current assets
Debtors
2
3,045,140
3,045,140
Net current assets
3,045,140
3,045,140
Capital and reserves
Called up share capital
3
65,000
65,000
Other reserves
35,000
35,000
Profit and loss reserves
2,945,140
2,945,140
Total equity
3,045,140
3,045,140

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2019 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 March 2020 and are signed on its behalf by:
Mr N Castle
Director
Company Registration No. 4276285
TANT LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
- 2 -
1
Accounting policies
Company information

Tant Laboratories Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 8, Bedwas Business Centre, Bedwas, CAERPHILLY, Mid Glamorgan, UK, CF83 8DU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared on the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

- Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

- Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;

- Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

 

The financial statements of the company are consolidated in the financial statements of Lenstec Optical Group Limited. These consolidated financial statements are available from its registered office, Unit 8 Bedwas Business Centre, Bedwas, Caerphilly CF83 8DU.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

TANT LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 3 -
1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Debtors
2019
2018
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
3,045,140
3,045,140
TANT LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 4 -
3
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
64,935 Ordinary A of £1 each
64,935
64,935
65 Ordinary B of £1 each
65
65
65,000
65,000
4
Related party transactions

Included in debtors is a balance of £3,045,140 (2018: £3,045,140) due from Lenstec Optical Group Limited, the ultimate parent company.

5
Parent company

The ultimate parent company is Lenstec Optical Group Limited, a company registered in England & Wales.

The ultimate controlling party is considered to be Mr N Castle due to his shareholding in Lenstec Optical Group Limited.

The consolidated accounts of Lenstec Optical Group Limited are publicly available and can be obtained from Companies House, Crown Way Maindy, Cardiff.

2019-12-312019-01-01true24 March 2020CCH SoftwareCCH Accounts Production 2020.100No description of principal activityMr G DonovanMr N CastleMr P WaldenMr G Donovan42762852019-01-012019-12-3142762852019-12-3142762852018-12-314276285core:ShareCapital2019-12-314276285core:ShareCapital2018-12-314276285core:OtherMiscellaneousReserve2019-12-314276285core:OtherMiscellaneousReserve2018-12-314276285core:RetainedEarningsAccumulatedLosses2019-12-314276285core:RetainedEarningsAccumulatedLosses2018-12-314276285core:ShareCapitalOrdinaryShares2019-12-314276285core:ShareCapitalOrdinaryShares2018-12-314276285bus:Director12019-01-012019-12-314276285core:CurrentFinancialInstruments2018-12-314276285bus:OrdinaryShareClass12019-01-012019-12-314276285bus:OrdinaryShareClass22019-01-012019-12-314276285bus:OrdinaryShareClass12019-12-314276285bus:OrdinaryShareClass22019-12-314276285bus:EntityNoLongerTradingButTradedInPast2019-01-012019-12-314276285bus:PrivateLimitedCompanyLtd2019-01-012019-12-314276285bus:SmallCompaniesRegimeForAccounts2019-01-012019-12-314276285bus:FRS1022019-01-012019-12-314276285bus:AuditExempt-NoAccountantsReport2019-01-012019-12-314276285bus:Director22019-01-012019-12-314276285bus:Director32019-01-012019-12-314276285bus:CompanySecretary12019-01-012019-12-314276285bus:FullAccounts2019-01-012019-12-31xbrli:purexbrli:sharesiso4217:GBP